Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Pharmacopsychiatry ; 50(4): 162-163, 2017 Jul.
Article in German | MEDLINE | ID: mdl-28511206

ABSTRACT

In the recent study by Verhoeven and Egger, 2015 and the recent letter to the editor by Boot et al. 2015 an emphasis is given to the best possible pharmacological treatment of 22q11-2 Deletion-Syndrome related psychoses. We would like to present the case of a 23-year old Cypriot patient with 22q11.2 deletion syndrome who fulfilled criteria for treatment resistant schizophrenia (TRS). He was sequentially treated with aripiprazole, risperidone, olanzapine, haloperidol and a combination treatment with olanzapine and haloperidol. Clozapine was the only antipsychotic medication that has improved his condition.


Subject(s)
Clozapine/therapeutic use , DiGeorge Syndrome/psychology , Drug Resistance/drug effects , Psychotic Disorders/drug therapy , Antipsychotic Agents/therapeutic use , DiGeorge Syndrome/complications , Humans , Male , Psychotic Disorders/complications , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...